This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Miller et al¹ pointed out the underutilization of lipid-lowering therapy in patients with coronary artery disease, especially in women.

We would like to present comparable results from the Bavarian Cholesterol Screening Project, which was initiated in 1988 as a population-based study.^2-3 Within the screening period of 10 years (1988-1998), 193,188 persons (54% women and 46% men) were screened all over Bavaria. Total cholesterol was measured by the Reflotron portable cholesterol analyzer (Boehringer Mannheim, Mannheim, Germany). For each person a short medical history was taken. The mean ± SD ages were 53 ± 17 years for the 104,244 screened women and 50 ± 18 years for the 88,944 screened men. The mean ± SD cholesterol levels were 6.24 ± 1.37 mmol/L (241 ± 53 mg/dL) for the women and 5.88 ± 1.40 mmol/L (227 ± 54 mg/dL) for the men.

In this sample, 4.8% of women (n = 5040) and 8.7% . . . [Full Text of this Article]

RELATED ARTICLE

Sex Bias and Underutilization of Lipid-Lowering Therapy in Patients With Coronary Artery Disease at Academic Medical Centers in the United States and Canada
Michael Miller, Robert Byington, Donald Hunninghake, Bertram Pitt, Curt D. Furberg, and for the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial Investigators
Arch Intern Med. 2000;160(3):343-347.
ABSTRACT | FULL TEXT